LifeStance Therapists & Psychiatrists Concord
925 Bradley Street Northeast, Concord
4.6(248 Google reviews)
United States
3 listed treatment centers serving Concord and the surrounding area.
925 Bradley Street Northeast, Concord
4.6(248 Google reviews)
925 Bradley Street Northeast, Suite C, Concord
4.7(23 Google reviews)
For people in Concord considering SPRAVATO®, the cost depends on insurance benefits, the treatment setting, and how services are billed. Both the medication and the supervised treatment visit, including monitoring, may generate charges. Ask for an estimate that accounts for both—not just the nasal spray.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials, including which medications you took and how you responded. Ask the treatment center what documentation it needs from your previous prescribers and who will submit the authorization request. Authorization does not necessarily mean every charge will be paid.
Medicare coverage may fall under Part B or Part D, depending on the plan and setting. North Carolina Medicaid coverage also depends on the applicable plan and setting. The three Concord listings in this directory are marked as not accepting Medicare or Medicaid; confirm current participation directly before scheduling.
Manufacturer savings programs exist for eligible commercially insured patients, but not for patients using government insurance. Eligibility restrictions apply, and assistance may not cover every visit-related charge.
Before starting Spravato, ask the center and your insurer:
Request written benefit information and a billing estimate before committing to repeated visits.
SPRAVATO® requires repeated visits to a REMS-certified healthcare setting. You administer the nasal spray yourself under direct observation of a healthcare provider; it is never sent home with you. This directory lists three Concord centers offering Spravato, but their REMS certification status is not documented here. Confirm certification and current treatment availability directly.
For treatment-resistant depression, the typical labeled schedule starts with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber individualizes the schedule; do not assume a particular frequency before your evaluation.
Reserve at least two hours for monitoring after each dose, plus time for check-in, dosing, and any additional assessment. Visits may therefore take longer than two hours overall. Discuss appointment availability before arranging time off work, childcare, or other responsibilities.
You need someone else to drive you home. You must not drive or operate machinery until the next day after a restful sleep. Arrange a reliable ride for every appointment and a backup if your usual driver cancels. Ask the center about its transportation and discharge requirements before relying on a hired ride.
If no Concord listing is available when you search, or the listed options cannot meet your needs, expand your search to listed centers in Charlotte or Huntersville. Confirm certification, appointment availability, insurance participation, and transportation feasibility before choosing an out-of-city location. A directory listing alone does not establish that a center is suitable for you.
This directory lists three Concord centers offering SPRAVATO®, but their REMS certification status is not documented in the listing data. Ask each center to confirm that the treatment location is currently REMS-certified and accepting patients. Also check insurance participation and scheduling. If Concord options do not work for you, the directory includes listings in Charlotte and Huntersville.
Spravato is FDA-approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must assess your history, current symptoms, and safety risks before recommending treatment.
Coverage depends on your plan and the treatment setting. Prior authorization and documentation of previous antidepressant trials are common requirements. Ask about coverage for both the medication and the monitored visit. The Concord listings are marked as not accepting Medicare or Medicaid, so verify current participation directly. Commercially insured patients can also ask whether they qualify for manufacturer savings assistance.
You self-administer the nasal spray under direct observation at a REMS-certified healthcare setting. Staff monitor you for at least two hours after each dose, including for sedation, dissociation, breathing problems, and blood pressure increases. Allow extra time beyond monitoring for other visit steps. Arrange a driver home; you cannot drive until the next day after a restful sleep.
Spravato has boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. Dissociation can feel like being detached from yourself or your surroundings. Blood pressure can also rise. It is a Schedule III controlled substance. Discuss your medical history, medications, and any substance-use concerns openly so the clinician can evaluate risks and explain monitoring.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behaviors, and it does not replace hospitalization when clinically needed. Do not wait for a treatment consultation if you need urgent help. In a crisis, call or text 988. If there is immediate danger or a medical emergency, call 911.
Approved uses, nearby treatment centers, and medically sourced patient guides.